Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Bacterial proteins with reactive cysteine residues represent a diverse functional group of proteins that utilize the nucleophilic properties of the cysteine thiol group for catalysis, regulation, and structural integrity. These proteins are critical for bacterial survival and pathogenesis, participating in essential processes such as peptidoglycan cell wall synthesis (e.g., MurA), protein folding and disulfide bond formation (e.g., DsbA), and the maintenance of redox homeostasis (e.g., Thioredoxin and OxyR) [Backus et al., 2016, Nature Chemical Biology]. The high nucleophilicity of specific "hotspot" cysteines makes these proteins susceptible to covalent modification by electrophilic small molecules, which can irreversibly inhibit their function [Kwon et al., 2020, JAC]. A prominent clinical example is the antibiotic fosfomycin, which targets the reactive Cys115 of MurA to block the first step of peptidoglycan biosynthesis [Skarzynski et al., 1996, Structure]. Beyond MurA, other targets include cysteine proteases like sortases in Gram-positive bacteria and various virulence factors [Mazmanian et al., 1999, Science]. However, the therapeutic challenge lies in achieving high selectivity for bacterial cysteines over the vast human "cysteineome" to minimize off-target toxicity and adverse effects [Vinogradova et al., 2020, Cell].
Covalent inhibition of essential bacterial enzymes through the alkylation or modification of reactive cysteine thiol groups, leading to irreversible loss of protein function [Skarzynski et al., 1996; Backus et al., 2016].
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Bacterial proteins with reactive cysteine residues.